FDA to Review Moderna's New Flu Vaccine Application
Moderna announced that the Food and Drug Administration (FDA) will review its amended application for a new flu vaccine, reversing a previous refusal that had raised concerns about the agency's regulatory approach under Health Secretary Robert F. Kennedy Jr. The vaccine, which utilizes mRNA technology, demonstrated greater effectiveness in a 40,000-person trial for adults aged 50 and older compared to standard flu shots. Moderna is seeking full approval for adults aged 50 to 64 and accelerated approval for those aged 65 and above, with a decision expected by August 5.
Microsoft's Project Silica Enables Millennia-Long Data Storage
Researchers at Microsoft have developed a new data storage medium using ordinary borosilicate glass, capable of retaining information for over 10,000 years. This system, known as Project Silica, utilizes femtosecond lasers to etch data into the glass, allowing it to store the equivalent of two million books in a thin, palm-sized square. The advancements reported in a paper published in Nature include improvements in cost and manufacturing, making this technology more accessible for long-term data preservation.
Research reveals 'death vortex' threatens Nevada golden eagles
Research on golden eagles in Nevada has identified a phenomenon known as the 'death vortex,' which is hindering the birds' reproduction and causing fatalities among raptors that attempt to inhabit the area. This finding highlights significant ecological challenges faced by these birds in the region.
Study reveals ancient mechanism for limb regeneration in species
Research indicates that the regeneration of fins and limbs in certain species, including hermit crabs, relies on a shared cellular mechanism, suggesting that the ability to regenerate complex tissues is an ancient trait. This regeneration often occurs after autotomy, a defense mechanism employed by hermit crabs to escape predators or in response to severe stress and environmental conditions.
